banner
4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside
Inquiry

Cat. No.: X24-11-LY448

4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside

Synonym: 67945-53-3; [(2R,3R,4S,5R,6R)-3,4,5-Triacetyloxy-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-2-yl]methyl acetate; 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside; 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-alpha-D-glucopyranoside; (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate

  • MDL: MFCD07369549
  • CAS Number: 67945-53-3
  • Compound CID: 71307138
img
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside is a MU substrate. It hydrolyzes in the action of the enzyme and releases a fluorescent 4-methyl coumarin.
Molecular Weight
506.46
Molecular Formula
C24H26O12
Form
Powder
Purity
≥95%
Applications
4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside is often used to determine the activity of α-D-glucosidase.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0